Menopause and Sleep Apnea: The Connection Most Women Don't Know About
By Glow Health | Menopause & Sexual Health Specialists
Sleep apnea is one of the most underdiagnosed conditions in women, and the menopausal transition is one of the primary reasons its prevalence increases so dramatically in midlife. Despite this, most women going through perimenopause and menopause are never screened for it. Their sleep complaints are attributed to night sweats or hormonal insomnia, treatment is directed at those targets, and sleep apnea quietly goes undetected.
This matters because untreated sleep apnea has serious health consequences, and because the symptoms of sleep apnea in women are frequently different from the classic presentation that most clinicians are trained to recognize.
What sleep apnea is
Sleep apnea is a condition in which breathing repeatedly stops and starts during sleep. The most common form is obstructive sleep apnea (OSA), in which the muscles of the upper airway relax during sleep and block airflow, causing brief interruptions in breathing that can occur dozens or even hundreds of times per night.
Each apnea event triggers a partial arousal from sleep as the brain responds to the drop in oxygen. These arousals are often too brief to be remembered but are sufficient to prevent the deep, restorative sleep stages that the body and brain need. The result is fragmented, unrefreshing sleep regardless of how many hours are spent in bed.
Why menopause increases sleep apnea risk
Before menopause, women have significantly lower rates of sleep apnea than men. Estrogen and progesterone appear to have a protective effect on upper airway muscle tone and respiratory drive, helping to keep the airway open during sleep. As these hormones decline during the menopausal transition, this protection is lost.
The data on this are striking. Studies have found that the prevalence of sleep apnea in postmenopausal women is two to three times higher than in premenopausal women of similar age and body weight. A large analysis from the Sleep Heart Health Study found that postmenopausal women not using hormone therapy had significantly higher rates of sleep-disordered breathing compared to premenopausal women and to postmenopausal women using hormone therapy, suggesting a direct hormonal contribution to the risk.
Weight gain around the time of menopause also contributes. Fat accumulation in the neck and upper airway increases the risk of airway obstruction, and the abdominal weight gain characteristic of the menopausal transition increases pressure on the diaphragm during sleep.
Why it goes undiagnosed in women
Sleep apnea in women presents differently than in men, and this difference has historically led to significant underdiagnosis.
The classic presentation in men, loud snoring, witnessed apneas, and excessive daytime sleepiness, is less reliably present in women. Women with sleep apnea are more likely to present with:
Insomnia and difficulty staying asleep
Fatigue and unrefreshing sleep rather than obvious daytime sleepiness
Morning headaches
Mood changes, anxiety, and depression
Cognitive symptoms including brain fog and poor concentration
Frequent nighttime waking
These symptoms overlap almost entirely with the common symptoms of perimenopause, which is precisely why sleep apnea in midlife women is so often missed. A woman presenting with these complaints in a menopause context may receive treatment directed at hormonal causes without ever being evaluated for sleep apnea.
This is compounded by the fact that clinicians, and women themselves, are less likely to consider sleep apnea as a possibility in a woman who does not fit the stereotypical profile of an overweight, middle-aged, loudly snoring man.
How sleep apnea affects health
The health consequences of untreated sleep apnea extend well beyond poor sleep:
Cardiovascular disease. Sleep apnea is independently associated with hypertension, arrhythmias, coronary artery disease, heart failure, and stroke. Each apnea event causes a surge in blood pressure and sympathetic nervous system activity that, repeated hundreds of times per night, takes a significant toll on the cardiovascular system over time. For midlife women who are already navigating increased cardiovascular risk from the menopausal transition, untreated sleep apnea is a meaningful additional burden.
Metabolic health. Sleep apnea worsens insulin resistance and is associated with increased risk of type 2 diabetes, independent of weight. The chronic intermittent hypoxia of sleep apnea affects glucose metabolism directly, compounding the metabolic changes of menopause.
Cognitive function. Sleep apnea impairs memory consolidation, executive function, and processing speed. In midlife women who are already experiencing hormonal effects on cognition, sleep apnea can significantly amplify cognitive symptoms. Emerging research also suggests associations between sleep apnea and increased long-term dementia risk.
Mood. Chronic sleep fragmentation from sleep apnea is associated with depression and anxiety, symptoms that are already more prevalent during the menopausal transition. Untreated sleep apnea can make mood symptoms significantly harder to manage.
Who should be evaluated
Any woman in perimenopause or postmenopause who is experiencing unrefreshing sleep, persistent fatigue, or cognitive symptoms that are not adequately explained by or treated through hormonal management should be evaluated for sleep apnea. Specific red flags include:
Waking with a headache in the morning
Being told by a partner that breathing pauses during sleep, or waking with a gasp or choking sensation
Significant daytime fatigue despite adequate time in bed
Mood or cognitive symptoms that are disproportionate to the degree of hormonal disruption
Hypertension that is difficult to control
Symptoms that persist despite treatment of vasomotor symptoms and hormonal insomnia
A formal sleep study, either an in-lab polysomnogram or a home sleep apnea test, is required to diagnose sleep apnea. Home testing has become increasingly accessible and is appropriate for many women as an initial evaluation.
Treatment
CPAP therapy
Continuous positive airway pressure (CPAP) is the most effective treatment for moderate to severe obstructive sleep apnea. A CPAP machine delivers a steady stream of pressurized air through a mask worn during sleep, keeping the upper airway open and preventing apnea events. For women who adhere to CPAP therapy, the improvements in sleep quality, energy, mood, and cognitive function can be dramatic.
CPAP has a reputation for being uncomfortable and difficult to tolerate, but significant advances in mask design, machine technology, and pressure delivery have made it substantially more manageable than it was in earlier generations of the device. Working with a sleep medicine specialist to find the right setup is worth the effort.
Oral appliances
For women with mild to moderate sleep apnea, a custom-fitted oral appliance made by a dentist trained in sleep medicine can be an effective alternative to CPAP. These devices reposition the jaw and tongue during sleep to keep the airway open. They are less effective than CPAP for severe apnea but significantly more tolerable for many women.
Positional therapy
For women whose sleep apnea occurs predominantly or exclusively when sleeping on their back, positional therapy, which involves strategies to encourage side sleeping, can meaningfully reduce apnea severity. This is rarely sufficient as a standalone treatment for moderate or severe apnea but can be a useful adjunct.
Weight management
Because excess weight, particularly around the neck and upper airway, contributes to sleep apnea risk, weight management can reduce severity. This is not always sufficient to resolve sleep apnea entirely, particularly in postmenopausal women, but it is a meaningful modifier.
Hormone therapy
The Sleep Heart Health Study data suggesting that postmenopausal women using hormone therapy have lower rates of sleep-disordered breathing raises the possibility that hormone therapy may have a protective or therapeutic effect on sleep apnea risk in this population. The mechanism is plausible given the role of estrogen and progesterone in maintaining upper airway muscle tone. This is not an established indication for hormone therapy, but it is another piece of the broader picture of how hormonal support during the menopausal transition benefits multiple systems simultaneously.
The importance of not assuming
The central clinical message of this post is that not all sleep disruption in perimenopause and menopause is hormonal, and that sleep apnea is common enough in this population to warrant active consideration rather than assumption. Treating hormonal causes of sleep disruption is appropriate and important, but it should not preclude evaluation for sleep apnea in women with persistent symptoms, particularly those with the red flags described above.
Both conditions can and do coexist. A woman can have hormonal insomnia and night sweats and sleep apnea. Treating one does not rule out the other, and fully restoring sleep often requires addressing both.
How Glow Health can help
At Glow Health, we take a comprehensive approach to sleep during the menopausal transition that includes awareness of sleep apnea as an important and underrecognized contributor. When symptoms suggest the possibility of sleep-disordered breathing alongside hormonal causes, we discuss evaluation and referral as part of an integrated approach to sleep and overall health.
If you are experiencing persistent, unrefreshing sleep that has not fully responded to hormonal treatment, that is a conversation worth having.
Keywords: menopause sleep apnea, sleep apnea women menopause, perimenopause sleep apnea, obstructive sleep apnea women, menopause and sleep disorders, sleep apnea symptoms women, menopause insomnia sleep apnea, postmenopause sleep apnea
This post is for informational purposes only and does not constitute medical advice. Please consult a qualified healthcare clinician for personalized guidance.
